ConductScience.org, home

Paper4359409

Biologically active components from mycobacterial cell walls. II. Suppression and regression of strain-2 guinea pig hepatoma.

Meyer TJ and 3 others. J Natl Cancer Inst, 1974. Cited by 131 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Biologically active components from mycobacterial cell walls. II. Suppression and regression of strain-2 guinea pig hepatoma. Papers, record 4359409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4359409

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Biologically active components from mycobacterial cell walls. II. Suppression and regression of strain-2 guinea pig hepatoma.
PubMed
Journal
J Natl Cancer Inst
PubMed
Year
1974
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
131
iCite
Relative citation ratio, by iCite
5.24
iCite
Revised in PubMed
2019-05-11
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Meyer TJT J
2Ribi EEE E
3Azuma II
4Zbar BB

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, HepatocellularMajor topic
Cell WallMajor topic
DisaccharidesMajor topic
GlycolipidsMajor topic
ImmunotherapyMajor topic
Liver NeoplasmsMajor topic
Mycobacterium bovisMajor topic
Mycolic AcidsMajor topic
PeptidesMajor topic
PolysaccharidesMajor topic
Animals
Guinea Pigs
Immunity
Male
Neoplasms, Experimental
Skin Tests
Trehalose

Source PubMed

Download CSV of topics

Cited by24

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 131 citations.

PMIDTitleJournalYearIn PapersSource
39204412Revitalizing Bacillus Calmette-Guérin Immunotherapy for Bladder Cancer: Nanotechnology and Bioengineering Approaches.Pharmaceutics2024https://conductscience.org/library/papers/39204412PubMed
27265565Mycobacteria emulsified in olive oil-in-water trigger a robust immune response in bladder cancer treatment.Sci Rep2016https://conductscience.org/library/papers/27265565PubMed
26834838The role of mycobacterial cell wall nucleic acid complex in the treatment of bacillus Calmette-Guérin failures for non-muscle-invasive bladder cancer.Ther Adv Urol2016https://conductscience.org/library/papers/26834838PubMed
18452561Activation of Toll-like receptor 2 by a novel preparation of cell wall skeleton from Mycobacterium bovis BCG Tokyo (SMP-105) sufficiently enhances immune responses against tumors.Cancer Sci2008https://conductscience.org/library/papers/18452561PubMed
7166915A patient with gastric carcinoma improved remarkably on intraperitoneal OK-432 therapy.Jpn J Surg1982https://conductscience.org/library/papers/7166915PubMed
6972900Failure of C3H mice to develop lung granuloma after intravenous injection of BCG cell wall vaccine. Demonstration of a defect in lymphoid cells.Immunology1981https://conductscience.org/library/papers/6972900PubMed
6389346Immunological evaluation of a component isolated from Mycobacterium bovis BCG with a monoclonal antibody to M. bovis BCG.Infect Immun1984https://conductscience.org/library/papers/6389346PubMed
3933816Anti-tumour activity of Lactobacillus casei on Lewis lung carcinoma and line-10 hepatoma in syngeneic mice and guinea pigs.Cancer Immunol Immunother1985https://conductscience.org/library/papers/3933816PubMed
3133110Antitumor effect of intrapleural administration of Lactobacillus casei in mice.Cancer Immunol Immunother1988https://conductscience.org/library/papers/3133110PubMed
2322938Parallel antitumor, granuloma-forming and tumor-necrosis-factor-priming activities of mycoloyl glycolipids from Nocardia rubra that differ in carbohydrate moiety: structure-activity relationships.Cancer Immunol Immunother1990https://conductscience.org/library/papers/2322938PubMed
1095912Cell walls of Mycobacteria and related organisms; chemistry and immunostimulant properties.Mol Cell Biochem1975https://conductscience.org/library/papers/1095912PubMed
826485Granulomagenic activity of serologically active glycolipids from Mycobacterium bovis BCG.Infect Immun1976https://conductscience.org/library/papers/826485PubMed
818016Adjuvant effect of cord factor, a mycobacterial lipid.Infect Immun1976https://conductscience.org/library/papers/818016PubMed
818013Analysis of the cell wall of five strains of Myocbacterium tuberculosis BCG and of an attenuated human strain, W 115.Infect Immun1976https://conductscience.org/library/papers/818013PubMed
804436Biologically active components from mycobacterial cell walls. III. Production of experimental allergic encephalomyelitis in guinea-pigs.Immunology1975https://conductscience.org/library/papers/804436PubMed
361572Immunotherapy of a guinea pig hepatoma with mycobacterial vaccines: comparison of BCG cell walls and cell wall skeletons.Infect Immun1978https://conductscience.org/library/papers/361572PubMed
203533Enhanced resistance against encephalomyocarditis virus infection in mice, induced by a nonviable Mycobacterium tuberculosis oil-droplet vaccine.Infect Immun1978https://conductscience.org/library/papers/203533PubMed
171670Enhancement of immunity against murine syngeneic tumors by a fraction extracted from non-pathogenic mycobacteria.Proc Natl Acad Sci U S A1975https://conductscience.org/library/papers/171670PubMed
166869Effect of Mycobacterium bovis and Mycobacterium tuberculosis on the take and survival of chickens with transplanted MC-29 hepatoma.Experientia1975https://conductscience.org/library/papers/166869PubMed
133083Adjuvant and mitogenic properties of a supernatant fraction of sonically treated Myobacterium bovis (BCG).Infect Immun1976https://conductscience.org/library/papers/133083PubMed

See all 24 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4359409

GET https://conductscience.org/api/papers/v1/4359409/cited_by?page=2